BioInvent International AB (publ) BOVNF

Set alert

Price alert · BOVNF

All alert types
0.61 USD -2.68 -81.46%

At close · Oct 30

0.6097 Day range 0.9299
0.6097 52-week range 3.29
YTD
-81.47%
1 year
-81.47%
Open
0.9299
Prev close
3.29
Mkt cap
40.12M
Vol
5.00K
Avg vol
46
EPS
-0.79
P/E
0.00
More statistics
Low
0.6097
High
0.9299

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for BOVNF has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-2.27 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C-1 / 5 overall

  • DCF 2
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 3
  • P/E 1
  • P/B 1

Valuation

P/E -6.0×
FY 2016: -7.3×FY 2017: -5.7×FY 2018: -5.5×FY 2019: -4.4×FY 2020: -15.4×FY 2021: -11.6×FY 2022: -88.9×FY 2023: -9.4×FY 2024: -8.0×FY 2025: -6.0×
FY 2016 5y median -9.4× FY 2025
P/S 8.8×
FY 2016: 6.4×FY 2017: 12.7×FY 2018: 17.6×FY 2019: 6.5×FY 2020: 8.0×FY 2021: 167×FY 2022: 9.2×FY 2023: 43.6×FY 2024: 76.4×FY 2025: 8.8×
FY 2016 5y median 43.6× FY 2025
P/B 3.6×
FY 2016: 2.0×FY 2017: 4.4×FY 2018: 7.8×FY 2019: 3.6×FY 2020: 1.6×FY 2021: 2.4×FY 2022: 1.9×FY 2023: 2.4×FY 2024: 3.9×FY 2025: 3.6×
FY 2016 5y median 2.4× FY 2025
P/FCF -7.8×
FY 2016: -5.9×FY 2017: -6.2×FY 2018: -4.7×FY 2019: -4.7×FY 2020: -17.0×FY 2021: -12.5×FY 2022: -56.1×FY 2023: -8.8×FY 2024: -8.7×FY 2025: -7.8×
FY 2016 5y median -8.8× FY 2025
EV/EBITDA -5.0×
FY 2016: -3.7×FY 2017: -4.8×FY 2018: -5.2×FY 2019: -3.7×FY 2020: -7.2×FY 2021: -9.0×FY 2022: -92.9×FY 2023: -9.2×FY 2024: -6.6×FY 2025: -5.0×
FY 2016 5y median -9.0× FY 2025
EV/Sales 7.3×
FY 2016: 3.2×FY 2017: 10.4×FY 2018: 15.8×FY 2019: 5.0×FY 2020: 3.1×FY 2021: 122×FY 2022: 7.7×FY 2023: 40.3×FY 2024: 67.1×FY 2025: 7.3×
FY 2016 5y median 40.3× FY 2025
FCF Yield -12.7%
FY 2016: -17.0%FY 2017: -16.1%FY 2018: -21.4%FY 2019: -21.4%FY 2020: -5.9%FY 2021: -8.0%FY 2022: -1.8%FY 2023: -11.4%FY 2024: -11.4%FY 2025: -12.7%
FY 2016 5y median -11.4% FY 2025

Profitability

Gross Margin 100.3%
FY 2016: 98.6%FY 2017: 93.6%FY 2018: 100.0%FY 2019: 100.0%FY 2020: 100.0%FY 2021: 100.0%FY 2022: 100.0%FY 2023: 100.0%FY 2024: 100.0%FY 2025: 100.3%
FY 2016 5y median 100.0% FY 2025
Operating Margin -155.1%
FY 2016: -88.2%FY 2017: -223.6%FY 2018: -319.7%FY 2019: -147.1%FY 2020: -51.2%FY 2021: -1436.0%FY 2022: -15.6%FY 2023: -517.7%FY 2024: -1054.2%FY 2025: -155.1%
FY 2016 5y median -517.7% FY 2025
Net Margin -147.0%
FY 2016: -87.8%FY 2017: -223.3%FY 2018: -319.5%FY 2019: -148.4%FY 2020: -52.0%FY 2021: -1439.1%FY 2022: -10.5%FY 2023: -462.2%FY 2024: -960.9%FY 2025: -147.0%
FY 2016 5y median -462.2% FY 2025
ROE -59.7%
FY 2016: -27.2%FY 2017: -77.2%FY 2018: -140.6%FY 2019: -82.1%FY 2020: -10.3%FY 2021: -20.4%FY 2022: -2.1%FY 2023: -25.2%FY 2024: -48.5%FY 2025: -59.7%
FY 2016 5y median -25.2% FY 2025
ROIC -62.1%
FY 2016: -27.3%FY 2017: -77.3%FY 2018: -140.6%FY 2019: -82.2%FY 2020: -10.0%FY 2021: -19.9%FY 2022: -3.1%FY 2023: -27.8%FY 2024: -52.2%FY 2025: -62.1%
FY 2016 5y median -27.8% FY 2025
ROA -49.6%
FY 2016: -22.7%FY 2017: -59.1%FY 2018: -102.3%FY 2019: -61.5%FY 2020: -9.6%FY 2021: -19.3%FY 2022: -2.0%FY 2023: -23.6%FY 2024: -43.4%FY 2025: -49.6%
FY 2016 5y median -23.6% FY 2025

Growth (YoY)

Revenue 405.6%
FY 2016: 347.6%FY 2017: -36.9%FY 2018: -14.4%FY 2019: 143.2%FY 2020: 57.2%FY 2021: -86.8%FY 2022: 1582.4%FY 2023: -78.1%FY 2024: -37.5%FY 2025: 405.6%
FY 2016 FY 2025
Operating Income 25.6%
FY 2016: 33.8%FY 2017: -60.1%FY 2018: -22.5%FY 2019: -11.9%FY 2020: 45.2%FY 2021: -268.8%FY 2022: 81.7%FY 2023: -626.5%FY 2024: -27.3%FY 2025: 25.6%
FY 2016 FY 2025
EPS (diluted) 22.4%
FY 2016: 60.4%FY 2017: -30.7%FY 2018: -10.3%FY 2019: 15.5%FY 2020: 64.5%FY 2021: -92.9%FY 2022: 89.3%FY 2023: -812.7%FY 2024: -30.1%FY 2025: 22.4%
FY 2016 FY 2025
Free Cash Flow 34.9%
FY 2016: -5.6%FY 2017: -19.4%FY 2018: -57.3%FY 2019: 11.0%FY 2020: 46.4%FY 2021: -273.8%FY 2022: 79.3%FY 2023: -562.3%FY 2024: -10.0%FY 2025: 34.9%
FY 2016 FY 2025

Financial Health

Current Ratio 5.7×
FY 2016: 5.9×FY 2017: 3.8×FY 2018: 3.1×FY 2019: 4.1×FY 2020: 14.4×FY 2021: 19.0×FY 2022: 12.4×FY 2023: 14.9×FY 2024: 9.9×FY 2025: 5.7×
FY 2016 5y median 12.4× FY 2025
Quick Ratio 5.6×
FY 2016: 5.9×FY 2017: 3.7×FY 2018: 3.0×FY 2019: 4.0×FY 2020: 14.4×FY 2021: 18.7×FY 2022: 12.3×FY 2023: 14.8×FY 2024: 9.8×FY 2025: 5.6×
FY 2016 5y median 12.3× FY 2025
Debt / Equity 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.1×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 1.0×
FY 2016: 3.7×FY 2017: 1.1×FY 2018: 0.6×FY 2019: 1.1×FY 2020: 11.2×FY 2021: 3.4×FY 2022: 18.0×FY 2023: 0.8×FY 2024: 0.9×FY 2025: 1.0×
FY 2016 5y median 1.0× FY 2025
Interest Coverage -872×
FY 2016: -6984×FY 2017: -25158×FY 2018: -20539×FY 2019: -286×FY 2020: -225×FY 2021: -538×FY 2022: -78.3×FY 2023: -580×FY 2024: -849×FY 2025: -872×
FY 2016 5y median -580× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31